ZA899961B - Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them - Google Patents

Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them

Info

Publication number
ZA899961B
ZA899961B ZA899961A ZA899961A ZA899961B ZA 899961 B ZA899961 B ZA 899961B ZA 899961 A ZA899961 A ZA 899961A ZA 899961 A ZA899961 A ZA 899961A ZA 899961 B ZA899961 B ZA 899961B
Authority
ZA
South Africa
Prior art keywords
fatty acid
saturated fatty
active substance
acid triglyceride
microgranulates
Prior art date
Application number
ZA899961A
Inventor
Jean-Claude Jamoulle
Jamoulle Jean-Claude
Josiane Allec
Allec Josiane
Alain Brzokewicz
Brzokewicz Alain
Braham Shroot
Shroot Braham
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of ZA899961B publication Critical patent/ZA899961B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Abstract

Microgranules loaded with a substance which is therapeutically active with respect to skin disorders and which melts on application to the skin. They are essentially formed by granulation of the abovementioned active substance using at least one saturated fatty acid triglyceride having a melting point of between 30 and 50 DEG C, the abovementioned microgranules having an average diameter of between approximately 5 mu m and 800 mu m. These microgranules find application in the treatment of skin disorders.
ZA899961A 1988-12-29 1989-12-28 Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them ZA899961B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU87416A LU87416A1 (en) 1988-12-29 1988-12-29 MICROGRANULES LOADED WITH AN ACTIVE SUBSTANCE, ESSENTIALLY CONSISTING OF A TRIGLYCERIDE OF SATURATED FATTY ACIDS AND THEIR TOPICAL USE IN THE THERAPEUTIC FIELD

Publications (1)

Publication Number Publication Date
ZA899961B true ZA899961B (en) 1990-10-31

Family

ID=19731128

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA899961A ZA899961B (en) 1988-12-29 1989-12-28 Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them

Country Status (16)

Country Link
EP (1) EP0376852B1 (en)
JP (1) JP2731008B2 (en)
KR (1) KR900009058A (en)
AT (1) ATE90869T1 (en)
AU (1) AU617570B2 (en)
CA (1) CA2006834A1 (en)
DE (2) DE376852T1 (en)
DK (1) DK669789A (en)
ES (1) ES2034951T3 (en)
FI (1) FI896321A0 (en)
GR (1) GR910300044T1 (en)
LU (1) LU87416A1 (en)
NO (1) NO895307L (en)
NZ (1) NZ231982A (en)
PT (1) PT92747A (en)
ZA (1) ZA899961B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649608B1 (en) * 1989-07-12 1991-10-11 Oreal COSMETIC COMPOSITION IN THE FORM OF AN AQUEOUS GEL CONTAINING SUSPENSION SPHEROIDS OF A NON-HYDROPHILIC SOLID LIPID SUBSTANCE
DE4336407A1 (en) * 1993-10-21 1995-04-27 Rotring Int Gmbh Waterproof cosmetics
FR2721210B1 (en) * 1994-06-17 1996-08-02 Oreal Cleaning composition containing lipid grains.
US5540920A (en) * 1994-11-22 1996-07-30 Olin Corporation Synergistic biocide composition containing pyrithione plus an additive
US5679648A (en) * 1994-11-30 1997-10-21 The University Hospital Methods for the treatment and prevention of fungal infections by administration of 3'-deoxypurine nucleosides
AT408067B (en) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION AND METHOD FOR THE PRODUCTION THEREOF
DE19511322C2 (en) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile eye gels containing medium chain triglycerides and process for their preparation
FR2737668B1 (en) * 1995-08-08 1997-10-31 Rocher Yves Biolog Vegetale BALLS BASED ON LIPOPHILIC SUBSTANCES, THEIR MANUFACTURING METHOD AND THEIR APPLICATIONS
JPH09268118A (en) * 1996-04-01 1997-10-14 Kao Corp Skin color-improving beautifier
DE19738247C2 (en) * 1997-09-02 2000-02-17 Goldwell Gmbh Hair care products
DE19952790A1 (en) * 1999-11-03 2001-05-17 Cognis Deutschland Gmbh Process for the production of fat granules
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
ITMI20012366A1 (en) * 2001-11-09 2003-05-09 Farmatron Ltd THERAPEUTIC SYSTEMS STABILIZED WITH IMMEDIATE RELEASE AND / OR MODIFIED FOR THE ORAL ADMINISTRATION OF ACTIVE AND / OR EXCIPIENT PRINCIPLES AND / OR WINGS
AU2003223005A1 (en) 2002-05-06 2003-11-17 Vectura Limited Application device for topical administration of pharmaceutical agents
US8980235B2 (en) * 2003-09-30 2015-03-17 Arch Chemicals, Inc. Coated metal pyrithione particles for treatment of microorganisms
US9861605B2 (en) 2011-10-24 2018-01-09 Stable Solutions Llc Enriched injectable emulsion containing selected fatty acid triglycerides
FR3075635B1 (en) * 2017-12-22 2019-12-06 Lvmh Recherche PROCESS FOR THE PREPARATION OF ANHYDROUS SPHEROIDS BY CRYOGENIA
KR102446371B1 (en) * 2019-06-11 2022-09-22 대봉엘에스 주식회사 Lipid composition and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB543309A (en) * 1940-12-04 1942-02-19 John David Evans Improvements in or relating to drugs
DE2309202A1 (en) * 1973-02-21 1974-08-29 Schering Ag MEDICINAL FORMS WITH MICRO-ENCAPSULATED MEDICINAL ACTIVE
DE2725924C3 (en) * 1977-06-08 1980-11-06 Hobeg Hochtemperaturreaktor-Brennelement Gmbh, 6450 Hanau Process for the production of spherical particles from low-melting organic substances

Also Published As

Publication number Publication date
GR910300044T1 (en) 1991-11-15
JP2731008B2 (en) 1998-03-25
FI896321A0 (en) 1989-12-28
KR900009058A (en) 1990-07-02
DE376852T1 (en) 1991-07-04
PT92747A (en) 1990-06-29
AU4730689A (en) 1990-07-05
NZ231982A (en) 1991-03-26
EP0376852A1 (en) 1990-07-04
LU87416A1 (en) 1990-07-10
DE68907335T2 (en) 1994-01-13
NO895307D0 (en) 1989-12-28
EP0376852B1 (en) 1993-06-23
JPH02300116A (en) 1990-12-12
DK669789D0 (en) 1989-12-28
NO895307L (en) 1990-07-02
ES2034951T3 (en) 1994-10-16
AU617570B2 (en) 1991-11-28
ATE90869T1 (en) 1993-07-15
ES2034951T1 (en) 1993-04-16
DK669789A (en) 1990-06-30
CA2006834A1 (en) 1990-06-29
DE68907335D1 (en) 1993-07-29

Similar Documents

Publication Publication Date Title
ZA899961B (en) Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them
AU7405387A (en) Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
DE68903442T2 (en) SOLID AND POROUS UNIT, CONTAINING MICROPARTICLES AND / OR NANOPARTICLES, AND METHOD FOR THE PRODUCTION THEREOF.
GR3005640T3 (en)
DK555389A (en) PHARMACEUTICAL PREPARATION
HUT49450A (en) Insecticides and acaricides containing as active substance derivatives of 2,2 difluor cycloprophil ethan and process for production of the active substance
NO932236D0 (en) PHARMACEUTICAL PREPARATION CONTAINING PROBUKOL WITH INCREASED BIO AVAILABILITY
NZ195058A (en) 2b-acetoxymethyl-(5r)-2-methyl-penam-3-carboxylic acid 1, 1-dioxide and salts and esters thereof pharmaceutical compositions
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
NO172495C (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE, NON-Saturated AMINO ACID COMPOUNDS
HUT44126A (en) Herbicide composition containing pyridine-monocarboxylic acid derivative with sulfur-containing group at the 5th position as active component and process for producing the active component
NO172491C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANE-ALCOHIC ACID DERIVATIVES
HUT44005A (en) Insecticide and acaricide compositions containing esters of carbamic acids as active components and process for producing the active components
IL61418A (en) Fluorine-substituted benzyl esters of 2,2,3,3-tetramethyl cyclopropane-1-carboxylic acid,their preparation and their use as pesticides
NO168825C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-PYRROLIDINYLTIO-1-AZABICYCLO (3.2.0) HEPT-2-EN-2 CARBOXYLIC ACID DERIVATIVES
HUT47895A (en) Insecticide and acaricide composition containing substituted phenyl-acetic acid ester derivatives as active components and process for producing the active components
NO863005D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4,5,6,7,8-HEXSAHYDRO-2-ALKYL-4-ARYL-5-OXO-1,7-NAFTYRIDINE-3-CARBOXYL ACID ESTER DERIVATIVES.
ES8704176A1 (en) Stabilized bacampicillin hydrochloride, process for the stabilization and pharmaceutical compositions.
AU1370188A (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance
NO165396C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDINE-5 CARBOXYLIC ACID ESTERS.
CS475388A1 (en) Mixed ester of succinic acid with 4-(3-alkoxy-3-alkyl-2-bromobutoxy)phenylalkanol and 3 beta,5-dihydroxy-5 alpha-cholestane-6-on as biologically active substance and method of its preparation
NO943458D0 (en) Process for the preparation of therapeutically active amphiregulin